FDA 483 - Christine H. Lee, M.D. - June 17, 2022
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
Christine H. Lee, M.D., a clinical investigator in Victoria, British Columbia, was cited for significant deviations in conducting two investigational new drug studies (2014-01 and 2017-01). The inspection revealed failures in following study protocols, including enrolling ineligible subjects, issues with informed consent, drug misadministration, and inadequate adverse event reporting. These findings indicate serious concerns regarding patient safety and data integrity in clinical trials.
ID · 7fc44400-715b-4f26-9dcd-ab637fca10ab